Physician profile
Jack B Sizemore
NPI 1255644126
$16,616.31
in general payments reported to CMS, 2019-2025
6 companies · $9,263 in 2025
The $9,263 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $141 · 2022: $283 · 2023: $2,861 · 2024: $4,069 · 2025: $9,263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $2,090 · Travel and Lodging: $1,947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,155.00 |
| Food and Beverage | $2,089.70 |
| Travel and Lodging | $1,947.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $16,313.90 | 2021-2025 | Zipseal 16 Surgical Skin Closure Kit, Zip 4 Surgical Skin Closure Device, Zipseal 24 Surgical Skin Closure Kit |
| Sanara Medtech INC. | $145.35 | 2024 | Celleraterx |
| Medical Device Business Services, INC. | $82.47 | 2021 | |
| Abbvie INC. | $32.27 | 2022 | |
| Ferring Pharmaceuticals INC. | $26.34 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.98 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Sizemore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.